Eli Lilly spent most of its 150-year history as a quiet insulin maker before a single drug reshuffled the entire obesity market and turned a modest stake into a fortune that left the S&P…
A Delaware jury just handed Arm a damaging verdict in its licensing battle with Qualcomm, and with a second ruling on its newest chip designs due next week, the pressure on the entire semiconductor…
While the broader market slides and AI darlings lose ground, Ford and GM are bucking the trend in afternoon trading, and the reason behind the rotation tells a bigger story about where investors think…
Moving to Florida or Texas wipes out state income tax, but a federal formula most retirees never see coming quietly cancels out a large share of those savings before the first year is even…
Broadcom's own CEO just flagged a threat that has nothing to do with chip supply, and it is hitting custom AI chip stocks far harder than the broader semiconductor market.
A Goldman Sachs survey found that more than a third of people earning over $300,000 still run out of money before the next paycheck, and for one of them, the gap between his working…
Bristol Myers Squibb has raised its dividend for 17 straight years, but a looming patent cliff and $43 billion in debt put the pace of future increases on a collision course with the drugs…
Dell just booked a record AI server backlog and its stock has already outpaced nearly every name on Wall Street this year, yet analysts say the real move may not have started yet. Here…
That number on your traditional IRA statement belongs partly to the IRS, and the share it claims grows larger the moment the account passes to your children. Here is what a $650,000 balance actually…